gynecology and obstetrics medical project, gynecology journal, obstetrics, gynecologic oncology, reproductive medicine, gynecological endoscopy, ultrasonography, gynecology articles

Ginekologia i Poloznictwo
ISSN 1896-3315 e-ISSN 1898-0759

Research - (2023) Volume 18, Issue 4

Evaluation of immunological markers among women with recurrent abortion in Thi-Qar province

Widyan Gataa Washel1*, Hassan Raysan Mobarak1 and Hind Muzhir Mousa2
 
*Correspondence: Dr. Widyan Gataa Washel, Department of Biology, College Education for Pure Sciences, University of Thi-Qar, Nasiriyah, Iraq, Email:

Received: 02-Dec-2023, Manuscript No. gpmp-23-121911; Editor assigned: 04-Dec-2023, Pre QC No. P-121911; Reviewed: 16-Dec-2023, QC No. Q-121911; Revised: 21-Dec-2023, Manuscript No. R-121911; Published: 29-Dec-2023

Author info »

Abstract

Many women around the world suffer from recurrent miscarriages associated with immune disorders Leading to decreased maternal and fetal tolerance. Thus, this study designed to evaluate the levels of Antiphospholipid antibodies (APL IgG & IgM and TGF-β1 in patients' women with recurrent abortions by using Enzyme-Linked Immune Sorbent Assay (ELISA). The current study included 100 women blood samples with recurrent miscarriage and 50 blood samples from apparently healthy women as control group their ages ranged between 17- 45 years. The results of the statistical analysis showed a significant increase in the levels of IgM, IgG and TGF-β1 in patients with recurrent miscarriage compared to the control group. Furthermore, highly significant positive strong correlation between IgM and IgG APL antibodies, and non-significant weak positive correlation between TGF-β and both antibodies (IgM and IgG APL) were indicated. In conclusion, TGF-β1 levels in miscarriage women are closely related to APLA levels during pregnancy and may have an influential role in pregnancy outcomes.

Keywords

Recurrent miscarriage; Antiphospholipid; TGF- β1 cytokine; ELISA

Introduction

Miscarriage is defined as the spontaneous loss of a pregnancy before the fetus reaches life, and as such includes all pregnancy losses from conception through 24 weeks of gestation [1].

Recurrent miscarriage, the spontaneous loss of two or more consecutive intra-uterine pregnancies with the same partner before 20 weeks’ gestation, is known to affect 0.5–2% of pregnant women [2]. It has been suggested that the causes are multi-factorial and might include parental chromosomal abnormalities, maternal thrombophilia, immune dysfunction and endocrine disorders [3]. Miscarriage is a common and distressing complication of early pregnancy whatever gestation it occurs at and whether it meets the terminology of a biochemical pregnancy or a clinical miscarriage [4]. An estimated 23 million miscarriages occur each year worldwide, which equates to 44 miscarriages every minute [5].

Antiphospholipid Syndrome (APS) is the most frequently diagnosed immunological cause of Recurrent Spontaneous Miscarriage (RSM) and the only proven thrombophilia associated with an adverse pregnancy outcome, and has also been identified as the most treatable cause of RSM [6]. APL is also associated with other symptoms, Obstetric complications, such as preeclampsia, intrauterine growth restriction, and prematurity [7]. Pervious study indicated that Antiphospholipid antibodies are an important cause of mid-trimester recurrent abortion in Iraqi women, with intermediate frequencies between Western and Indian reports [8].

Transforming Growth Factor –Beta1 (TGF-β1) is a pleiotropic cytokine that functions in tissue fibrosis, wound healing, and embryonic development [9]. It stimulates the production of Regulatory T cells (Tregs), maintain and mediate the immunosuppressive function of Tregs cells, the balance of M1/M2 macrophage, also has a role in regulation function of natural killer cell. Thus, it is maintaining the immune tolerance of the fetus and mother.

In addition to some studies showed that TGF-β1 is dysregulated in patients with recurrent spontaneous abortion or preeclampsia [10].

Based on what previous studies marked about the relationship of antiphospholipid antibodies to recurrent miscarriage and the role that TGF-β plays in maintaining pregnancy and preventing miscarriage, this study was designed to evaluate the levels of antiphospholipid antibodies (APL IgG, IgM,) and TGF-β antibodies in women with recurrent miscarriage in Thi Qar Governorate.

Materials and Methods

Sample collection

This study conducted in Labs of Collage of Education for Pure Science/Thi-Qar university in collaboration with of Bunt Al-Huda Hospital Teaching Hospital, Thi-Qar, Iraq during the period from 1st of February 2023 to 31st August 2023.

Overall, 150 people were enrolled in this study, one hundred of whom were women with recurrent miscarriage who were divided into three groups according to age, and fifty healthy women as a control group, aged 17- 45 years. All participating women were evaluated for specific antiphospholipid antibodies IgM, IgG, and TGF-β1 using enzyme-linked immunosorbent assay ELISA (Biotic, USA)

Statistical analysis

The statistical analysis program SPSS was used to analyze the results of the current study, where the independent student t-test was used to compare means between two groups, and Person′s correlation coefficient test that measured linear correlation between studied parameters at (P. value <0.05, P. value <0.01)

Results

Tab.1. showed the value of Immunological Parameters results in miscarriages women and healthy women control group. The current findings showed that women with recurrent miscarriage abortion had an increased serum level of all involved immunological parameters, compared with the healthy women with significant difference at p. value <0.05.

Immunological Parameters Patients Control T test P value
Mean ± S. D
TGF-β1 7.64 ± 2.79 6.27 ± 2.14 < 0.01**
APL IgM 0.80 ± 0.39 0.64 ± 0.17 < 0.01**
APL IgG 0.39 ± 0.13 0.25 ± 0.07 < 0.01**

Tab. 1. Sera levels of immunological parameters in patients women and healthy groups.

Regarding to the APL antibodies results, the current study showed highly significant increase (P ≤ 0.05) in the concentration of both types of antiphospholipid antibodies (IgM, IgG) in serum of patients women group with miscarriage abortion compared to a healthy control group, and APL (IgM) appeared higher concentration than APL (IgG).

According to Person′s correlation coefficient between study parameters the present results indicated highly significant positive strong correlation between IgM and IgG APL antibodies, while non-significant weak positive correlation between TGF-β and both antibodies (IgM and IgG APL) as in Tab. 2.

Person IgM IgG
TGF-β1 r 0.050 0.120
p. value 0.622 0.233
IgM r - 0.702**
p. value 0.00

Tab. 2. Person correlation between immunological parameters.

Discussion

These results are consistent with the results of a local study in Thi Qar conducted by Hamadi and Lafta, which indicated increased APA IgG/IgM in patients with recurrent miscarriage compared with the control group. They also found that the positive rates of APL (IgM) were higher than APL (IgG) [11].

Also, the same results were confirmed by Ilyas, et al. who found that the percentages of positivity for APL (IgM) are higher than for APL (IgG) [12].

This an elevated levels of IgM antibodies may be due to the transient and non-specific nature of these antibodies, where increase secondarily after exposure to drugs and infections. Whereas antiphospholipid IgG antibodies are more specific and are commonly associated with thrombosis, thrombocytopenia, and recurrent miscarriage [13].

The high results of these ApLs were directly involved in thrombosis that leading to placental infarction and fetal death, a previous study indicated that antibodies against APL target the placenta and stimulate platelet and endothelial cell activation, leading to a prothrombotic state. But all this is not enough to cause fetal loss or delayed growth. Some minor mediators such as C3a, C5a and C5b-9 MAC are produced by complement activation leading to inflammation, tissue damage and finally fetal loss via enhancement of platelets and endothelium Cell activation [14].

Moreover, the current results showed an increase in TGF-β1 mean concentration levels among the group of patient women compared to the healthy pregnant control group, Table 1. These results are consistent with two previous Iraqi studies that indicated a significant increase in the mean levels of the anti-inflammatory marker (TGF-β) in women with recurrent miscarriage compared to healthy pregnant women [15,16]. This is also in line with Ogasawara, et al. who found that TGF-beta levels among pregnant women who had miscarriages were significantly higher than among control pregnant women, and concluded that TGF-beta1 may be important for maintaining pregnancy but may also be a risk factor for recurrent miscarriage [17].

While the current findings contradicts the results of a recent study that showed significantly higher levels for TFG- in women without a history of recurrent miscarriage compared to women with a history of recurrent miscarriage [18]. Huber, et al. indicated that the serum TGF-beta1 levels, does not appear to have a role in the pathogenesis of preeclampsia [19].

These differences among the results of studies may be due to variety of the time and place of sample collection, the techniques and kits used for diagnosis, and the size or types of samples tested.

TGF-β has a cardinal role in maintaining peripheral tolerance to self and harmless antigens, such as fetal alloantigens [10, 20].

Previous data published by Magdoud and his colleagues provided the first evidence on the effect of TGF-β genotype in spontaneous abortion, and they indicated the important role that TGF-β plays in pregnancy outcomes [21].

Antiphospholipid antibodies are acquired autoantibodies against phospholipids that linked with slow progressive thrombosis and placental infarction. Phospholipids present in the blood play an important role in the blood clotting process. In some people, the body mistakenly identifies phospholipids as foreign substances and forms antibodies against them. As a result of confusion in the immune system, which leads to the autoimmune disorder [22].

Many studies indicated that the levels of both antibodies (IgM and IgG APL) increased in patients with recurrent miscarriage [11-12].

Jakiela, et al. founded that the TGF- β1 production were decreased in primary antiphospholipid syndrome PAPS patients with high levels of aPL IgG [22].

The study concluded that significantly elevated TGF-β1 levels in recurrent aborted women are closely related to APLA levels during pregnancy and may have an influential role in pregnancy outcomes.

Conclusion

The study concluded that significantly elevated TGF-β1 levels in recurrent aborted women are closely related to APLA levels during pregnancy and may have an influential role in pregnancy outcomes.

Disclosure

None.

Funding

None.

Authors Contribution

(A) Study Design · (B) Data Collection . (C) Statistical Analysis · (D) Data Interpretation · (E) Manuscript Preparation · (F) Literature Search · (G) No Fund Collection

References

  1. Regan L, Rai R, Saravelos S, et al. Recurrent MiscarriageGreen‐top Guideline No. 17. BJOG: Int J Obstet Gynaecol. 2023;130(12):e9-39.

    Google Scholar, Crossref, Indexed at

  2. McPherson E. Recurrence of stillbirth and second trimester pregnancy loss. Am J Med Genet A. 2016;170(5):1174-1180.

    Google Scholar, Crossref, Indexed at

  3. Larsen EC, Christiansen OB, Kolte AM, et al. New insights into mechanisms behind miscarriage. BMC Med. 2013;11(1):1-0.

    Google Scholar, Crossref, Indexed at

  4. Loss RP. Guideline of the European society of human reproduction and embryology. ESHRE Early Preg Guidline Develop Group. 2017:1-53.

    Google Scholar

  5. Quenby S, Gallos ID, Dhillon-Smith RK, et al. Miscarriage matters: The epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397(10285):1658-1667.

    Google Scholar, Crossref, Indexed at

  6. Diejomaoh MF. Recurrent spontaneous miscarriage is still a challenging diagnostic and therapeutic quagmire. Med Princ Pract. 2014;24(Suppl. 1):38-55.

    Google Scholar, Crossref, Indexed at

  7. Cervera R. Antiphospholipid syndrome. Thromb Res.2017;151:S43-S47.

    Google Scholar, Crossref, Indexed at

  8. Al-Samarrai AA, Hilmi FA, Al-Allawi NA, et al. Antiphospholipid antibodies in Iraqi women with recurrent mid-trimester abortions. J Lab Physicians. 2012;4(02):078-82.

    Google Scholar, Crossref, Indexed at

  9. Park JH, Li L, Baek KH. Study of the association of the T869C polymorphism of the transforming growth factor-β1 gene with polycystic ovary syndrome. Mol Med Rep. 2015;12(3):4560-4565.

    Google Scholar, Crossref, Indexed at

  10. Yang D, Dai F, Yuan M, et al. Role of transforming growth factor-β1 in regulating fetal-maternal immune tolerance in normal and pathological pregnancy. Front Immunol. 2021;12:689181.

    Google Scholar, Crossref, Indexed at

  11. Hamadi GM, Lafta SF. Immunological parameters of recurrent miscarriages among women in Thi-Qar province. J Med Life. 2022;15(5):635.

    Google Scholar, Crossref, Indexed at

  12. Ilyas SM, Dar LR, Rasool G, et al. Levels of antiphospholipid antibodies in females with recurrent abortions. Ann Pak Inst Med Sci. 2011;7(3):156-159.

    Google Scholar

  13. Daboubi MK. Anticardiolipin antibodies in women with recurrent abortion. East Mediterr Health J. 2001;7 (1-2), 95-99.

    Google Scholar

  14. Samarkos M, Mylona E, Kapsimali V. The role of complement in the antiphospholipid syndrome: A novel mechanism for pregnancy morbidity. Semin Arthritis Rheum. 2012; 42(1):66-69.

    Google Scholar, Crossref, Indexed at

  15. Kadhim WH, Tektook NH, Khalaf AK. Study the correlation between cytokines (IL-6, IL-27, TGF-beta and IFN-gamma) levels and microbial abortion among woman in Thi-Qar Province. Int J Biol Chem Sci. 2020;13:40-48.

    Google Scholar, Indexed at

  16. Abdulkhaliq RJ, Mohammed ST, Abbas AA. The role of IL-6 and TGF-β1 in Iraqi women with recurrent abortion. J Global Pharm Tech. 2018; 10(03):633-639.

    Google Scholar, Indexed at

  17. Ogasawara MS, Aoki K, Aoyama T, et al. Elevation of transforming growth factor-β1 is associated with recurrent miscarriage. J Clin Immunol. 2000;20:453-457.

    Google Scholar, Crossref, Indexed at

  18. Dirisipam K, Madduru D, Jahan P, et al. Can circulating levels of transforming growth factor-β1 in early pregnancy serve as a predictive marker of unfavourable outcome?. Placenta. 2023;137:65-69.

    Google Scholar, Crossref, Indexed at

  19. Huber A, Hefler L, Tempfer C, et al. Transforming growth factor‐beta 1 serum levels in pregnancy and pre‐eclampsia. Acta Obstet Gynecol Scand. 2002;81(2):168-171.

    Google Scholar, Crossref, Indexed at

  20. Sanjabi S, Oh SA, Li MO. Regulation of the immune response by TGF-β: from conception to autoimmunity and infection. Cold Spring Harb Perspect Biol. 2017;9(6):a022236.

    Google Scholar, Crossref, Indexed at

  21. Magdoud K, Granados Herbepin V, Messaoudi S, et al. Genetic variation in TGFB1 gene and risk of idiopathic recurrent pregnancy loss. Mol Hum Reprod. 2013;19(7):438-443.

    Google Scholar, Crossref, Indexed at

  22. Jakiela B, Iwaniec T, Plutecka H, et al. Signs of impaired immunoregulation and enhanced effector T-cell responses in the primary antiphospholipid syndrome. Lupus. 2016;25(4):389-398.

    Google Scholar, Crossref, Indexed at

Author Info

Widyan Gataa Washel1*, Hassan Raysan Mobarak1 and Hind Muzhir Mousa2
 
1Department of Biology, College Education for Pure Sciences, University of Thi-Qar, Nasiriyah, Iraq
2Department of Pathological Analysis, College of Science, University of Thi-Qar, Nasiriyah, Iraq
 

Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.